NEO Payments for Repurchase of Redeemable Preferred Stock

NeoGenomics, Inc. Payments for Repurchase of Redeemable Preferred Stock

Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).

NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for the quarter ending 2019-12-31 was $0.00.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for the quarter ending 2019-09-30 was $0.00.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for the quarter ending 2018-12-31 was $0.00.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for the quarter ending 2018-09-30 was $0.00.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for fiscal 2020 was $0.00.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for fiscal 2018 was $50.10M.
NeoGenomics, Inc. payments for repurchase of redeemable preferred stock for fiscal 2017 was $0.00.

Period end	Payments for Repurchase of Redeemable Preferred Stock 3 month	Payments for Repurchase of Redeemable Preferred Stock 12 month
2020-12-31		$0.00 10-K · filed 2021-02-25
2019-12-31	$0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25	$0.00 10-K · filed 2021-02-25
2019-09-30	$0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
2018-12-31	$0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25	$50.10M 10-K · filed 2021-02-25
2018-09-30	$0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
2017-12-31	$0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28	$0.00 10-K · filed 2020-02-28
2017-09-30	$0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06

Stock Name	Country	Market Cap	PE Ratio
20/20 Biolabs, Inc. (AIDX)	United States	$0.005B